Zibo Qixiang Tengda Chemical Co., Ltd. Independent Director 2025 Annual Performance Report (Liu Haibo)
As an independent director of Zibo Qixiang Tengda Chemical Co., Ltd. (hereinafter referred to as the "Company") for the sixth board of directors, in my work during the 2025 fiscal year, I strictly followed the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Securities Law of the People's Republic of China" (hereinafter referred to as the "Securities Law"), the "Guiding Opinions on the Management of Independent Directors of Listed Companies," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Normative Operation of Main Board Listed Companies," the "Articles of Association" and the Company's "Independent Director System," and other relevant laws and regulations. With the principles of independence, objectivity, and fairness, I diligently exercised my duties as an independent director, effectively safeguarding the legitimate rights and interests of the Company, all shareholders, especially small and medium shareholders. The following is a report on my performance in 2025:
I. Basic Information of Independent Directors
I, Liu Haibo, am a member of the Communist Party of China, hold a bachelor's degree, and am a Chinese national with no permanent right of abode overseas. I currently serve as the Director and Party Branch Secretary of Shandong Quanzheng (Linzi) Law Firm, and concurrently as an independent director of the Company's sixth board of directors and an independent director of Blue Sail Medical Co., Ltd.